ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Depressin Screening and Care Program at Community Health Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01626703
Recruitment Status : Completed
First Posted : June 25, 2012
Last Update Posted : March 10, 2016
Sponsor:
Information provided by (Responsible Party):
Hyeon Woo Yim, National Clinical Research Coordination Center, Seoul, Korea

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate.

Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.


Condition or disease Intervention/treatment Phase
Depression Screening Elderly Other: Reminding call Not Applicable

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 86 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Screening
Study Start Date : June 2012
Actual Primary Completion Date : December 2012
Actual Study Completion Date : March 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: intervention
remiding call
 Other: Reminding call
No Intervention: Control
No intervention


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Reuptake rate [ Time Frame: 12 weeks ]

Secondary Outcome Measures :
  1. reduced depressive symptoms [ Time Frame: 12 weeks ]
    Geriatric Depression Scale Short Form (SGDS)

  2. changed perceived heath status [ Time Frame: 12 weeks ]
    Visual Analogue Scale (VAS)


Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 60 or more
  • 10 or more in GDS scor

Exclusion Criteria:

  • severe cognitive problem
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01626703


Locations
Korea, Republic of
Chungju community health care center
Chungju, Choongbuk, Korea, Republic of, 123456
Sponsors and Collaborators
National Clinical Research Coordination Center, Seoul, Korea
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Hyeon Woo Yim, professor, National Clinical Research Coordination Center, Seoul, Korea
ClinicalTrials.gov Identifier: NCT01626703     History of Changes
Other Study ID Numbers: A102065_2012_2
First Posted: June 25, 2012    Key Record Dates
Last Update Posted: March 10, 2016
Last Verified: March 2016